187 related articles for article (PubMed ID: 31369732)
1. The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81.
Witkin JM; Ping X; Cerne R; Mouser C; Jin X; Hobbs J; Tiruveedhula VVNPB; Li G; Jahan R; Rashid F; Kumar Golani L; Cook JM; Smith JL
Brain Res; 2019 Nov; 1722():146356. PubMed ID: 31369732
[TBL] [Abstract][Full Text] [Related]
2. The Positive Allosteric Modulator of
Witkin JM; Li G; Golani LK; Xiong W; Smith JL; Ping X; Rashid F; Jahan R; Cerne R; Cook JM; Jin X
J Pharmacol Exp Ther; 2020 Jan; 372(1):83-94. PubMed ID: 31694876
[TBL] [Abstract][Full Text] [Related]
3. Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611).
Witkin JM; Schober DA; Gleason SD; Catlow JT; Porter WJ; Reel J; Jin X; Hobbs J; Gehlert D; Gernert DL; Gardinier KM; Kato AS; Ping X; Smith JL
CNS Neurol Disord Drug Targets; 2017; 16(10):1099-1110. PubMed ID: 29090671
[TBL] [Abstract][Full Text] [Related]
4. Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism.
Kato AS; Burris KD; Gardinier KM; Gernert DL; Porter WJ; Reel J; Ding C; Tu Y; Schober DA; Lee MR; Heinz BA; Fitch TE; Gleason SD; Catlow JT; Yu H; Fitzjohn SM; Pasqui F; Wang H; Qian Y; Sher E; Zwart R; Wafford KA; Rasmussen K; Ornstein PL; Isaac JT; Nisenbaum ES; Bredt DS; Witkin JM
Nat Med; 2016 Dec; 22(12):1496-1501. PubMed ID: 27820603
[TBL] [Abstract][Full Text] [Related]
5. Auxiliary subunits of AMPA receptors: The discovery of a forebrain-selective antagonist, LY3130481/CERC-611.
Kato AS; Witkin JM
Biochem Pharmacol; 2018 Jan; 147():191-200. PubMed ID: 28987594
[TBL] [Abstract][Full Text] [Related]
6. The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders.
Witkin JM; Lippa A; Smith JL; Jin X; Ping X; Biggerstaff A; Kivell BM; Knutson DE; Sharmin D; Pandey KP; Mian MY; Cook JM; Cerne R
Pharmacol Biochem Behav; 2022 Feb; 213():173321. PubMed ID: 35041859
[TBL] [Abstract][Full Text] [Related]
7. Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects.
Knutson DE; Smith JL; Ping X; Jin X; Golani LK; Li G; Tiruveedhula VVNPB; Rashid F; Mian MY; Jahan R; Sharmin D; Cerne R; Cook JM; Witkin JM
ACS Chem Neurosci; 2020 Sep; 11(17):2624-2637. PubMed ID: 32786313
[TBL] [Abstract][Full Text] [Related]
8. AMPA receptors in epilepsy and as targets for antiepileptic drugs.
Rogawski MA; Donevan SD
Adv Neurol; 1999; 79():947-63. PubMed ID: 10514878
[TBL] [Abstract][Full Text] [Related]
9. Structural Determinants of the γ-8 TARP Dependent AMPA Receptor Antagonist.
Lee MR; Gardinier KM; Gernert DL; Schober DA; Wright RA; Wang H; Qian Y; Witkin JM; Nisenbaum ES; Kato AS
ACS Chem Neurosci; 2017 Dec; 8(12):2631-2647. PubMed ID: 28825787
[TBL] [Abstract][Full Text] [Related]
10. Modulation of TARP
Knopp KL; Simmons RMA; Guo W; Adams BL; Gardinier KM; Gernert DL; Ornstein PL; Porter W; Reel J; Ding C; Wang H; Qian Y; Burris KD; Need A; Barth V; Swanson S; Catlow J; Witkin JM; Zwart R; Sher E; Choong KC; Wall TM; Schober D; Felder CC; Kato AS; Bredt DS; Nisenbaum ES
J Pharmacol Exp Ther; 2019 Jun; 369(3):345-363. PubMed ID: 30910921
[TBL] [Abstract][Full Text] [Related]
11. Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptors.
Witkin JM; Li J; Gilmour G; Mitchell SN; Carter G; Gleason SD; Seidel WF; Eastwood BJ; McCarthy A; Porter WJ; Reel J; Gardinier KM; Kato AS; Wafford KA
Neuropharmacology; 2017 Nov; 126():257-270. PubMed ID: 28757050
[TBL] [Abstract][Full Text] [Related]
12. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
[TBL] [Abstract][Full Text] [Related]
13. Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABA
Witkin JM; Smith JL; Ping X; Gleason SD; Poe MM; Li G; Jin X; Hobbs J; Schkeryantz JM; McDermott JS; Alatorre AI; Siemian JN; Cramer JW; Airey DC; Methuku KR; Tiruveedhula VVNPB; Jones TM; Crawford J; Krambis MJ; Fisher JL; Cook JM; Cerne R
Neuropharmacology; 2018 Jul; 137():332-343. PubMed ID: 29778948
[TBL] [Abstract][Full Text] [Related]
14. The α2,3-selective potentiator of GABA
Witkin JM; Cerne R; Davis PG; Freeman KB; do Carmo JM; Rowlett JK; Methuku KR; Okun A; Gleason SD; Li X; Krambis MJ; Poe M; Li G; Schkeryantz JM; Jahan R; Yang L; Guo W; Golani LK; Anderson WH; Catlow JT; Jones TM; Porreca F; Smith JL; Knopp KL; Cook JM
Pharmacol Biochem Behav; 2019 May; 180():22-31. PubMed ID: 30825491
[TBL] [Abstract][Full Text] [Related]
15. Perampanel: Does it have broad-spectrum potential?
Potschka H; Trinka E
Epilepsia; 2019 Mar; 60 Suppl 1():22-36. PubMed ID: 29953584
[TBL] [Abstract][Full Text] [Related]
16. BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy.
Faught E
Expert Opin Investig Drugs; 2014 Jan; 23(1):107-13. PubMed ID: 24147649
[TBL] [Abstract][Full Text] [Related]
17. AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.
Di Bonaventura C; Labate A; Maschio M; Meletti S; Russo E
Expert Opin Pharmacother; 2017 Nov; 18(16):1751-1764. PubMed ID: 29023170
[TBL] [Abstract][Full Text] [Related]
18. GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABA
Cerne R; Lippa A; Poe MM; Smith JL; Jin X; Ping X; Golani LK; Cook JM; Witkin JM
Pharmacol Ther; 2022 Jun; 234():108035. PubMed ID: 34793859
[TBL] [Abstract][Full Text] [Related]
19. Research advances in basic mechanisms of seizures and antiepileptic drug action.
Lasoń W; Chlebicka M; Rejdak K
Pharmacol Rep; 2013; 65(4):787-801. PubMed ID: 24145073
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABA
Lewter LA; Fisher JL; Siemian JN; Methuku KR; Poe MM; Cook JM; Li JX
ACS Chem Neurosci; 2017 Jun; 8(6):1305-1312. PubMed ID: 28150939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
